MedPath

Plantago seed

Generic Name
Plantago seed
Brand Names
Konsyl, Metamucil, Reguloid
Drug Type
Biotech
Chemical Formula
-
CAS Number
8063-16-9
Unique Ingredient Identifier
9C60Y73166
Background

Platango seeds refer to the seeds collected from various species of plantago trees. It is found in some laxatives for treating occasional constipation and restoring regularity in bowel movements. Its potential benefit in maintaining remission in ulcerative colitis has been studied .

Regardless, this agent is most predominantly used as a gentle laxative agent in many parts of the world that is more commonly referred as psyllium or psyllium husk.

Indication

Indications include the treatment of patients needing a high fibre regime, perhaps for: (a) the relief of constipation, including constipation in pregnancy and the maintenance of regularity; (b) the management of bowel function in patients with colostomy, ileostomy, hemorrhoids, anal fissure, chronic diarrhea with diverticular disease, irritable bowel syndrome, and ulcerative colitis .

Associated Conditions
Bowel Motility, Constipation
Associated Therapies
-
mayoclinic.org
·

Crohn's disease - Diagnosis and treatment

Crohn's disease diagnosis involves ruling out other causes and using tests like blood tests, stool studies, colonoscopy, CT scans, MRI, and capsule endoscopy. Treatment aims to reduce inflammation and improve long-term prognosis, using anti-inflammatory medicines, immune system suppressors, biologics, JAK inhibitors, antibiotics, and other medicines. Surgery may be necessary, but it doesn't cure the disease. Lifestyle changes, diet adjustments, and stress management can help manage symptoms.
urotoday.com
·

PARTIQoL Trial: Proton Therapy vs IMRT for Localized Prostate Cancer

Jason Efstathiou discusses the PARTIQoL trial, comparing proton beam therapy to IMRT for localized prostate cancer, focusing on patient-reported outcomes and bowel function at 24 months. The trial, involving 450 patients from 29 centers, employs innovative strategies to overcome accrual challenges, emphasizing rigorous data generation to assess proton therapy's benefits. Despite proton therapy's potential advantages, its limited availability and high costs in the U.S. highlight the need for comparative studies like PARTIQoL.
© Copyright 2025. All Rights Reserved by MedPath